Search results: Sage Journals

Restricted accessResearch articleFirst published October, 2006

Drugs — Product or Service?

Claus Møldrup, Poul R. Kruse

Journal of Medical Marketing: Device,Diagnostic and Pharmaceutical Marketing

Restricted accessResearch articleFirst published April, 2005

Germany Enacts a Biotechnology Patent Law;AVI BioPharm Receives Stem Cell Antisense Technology Patent and Allowance;Third Amendment to Indian Patent Law Takes Effect;U.S.,Israel in Dispute over Patent Law on Drugs

Biotechnology Law Report

Restricted accessResearch articleFirst published October, 2006

Sanofi,Bristol-Myers Subject of DoJ Investigation;Two Groups Try for Revocation of Human Embryonic Stem Cell Patents;Neuralstem Patent Survives Third Challenge;A Round-Up of New Patents;Protiva Sues Inex

Biotechnology Law Report

Restricted accessNewsFirst published March, 1985

<Blr 349> Text: Speech By Rene G. Tegtmeyer,Assistant Commissioner For Patents,U.S. Patent And Trademark Office,At Third Annual Meeting Of Industrial Biotechnology Association,October 17-18,1984,San Francisco

Biotechnology Law Report

Restricted accessResearch articleFirst published August, 2016

The Medicines Company v. Hospira : When Does Outsourcing Drug Manufacture to a Third-Party Contractor Trigger an On-Sale Bar to Patentability?

Christopher M. Holman

Biotechnology Law Report

Restricted accessResearch articleFirst published April, 2007

MedImmune Case Gets More Complicated: Supreme Court Gives Company Right to Sue,But PTO Revokes Cabilly II for Double Patenting;Israeli Firm Does Not Own Patent on Rheumatoid Arthritis Treatment;Lilly Keeps Its Anti-Schizophrenia Drug Patent;A Win for Abbott;More Trouble for ImClone;Infringement of Ethanol-Manufacture Patent Found to Be Willful;Stratagene,Third Wave Settle PCR Suits;Short Stories

Biotechnology Law Report

Restricted accessResearch articleFirst published March, 2012

Overcoming challenges in market access of generic medicines in the European Union

Pieter Dylst, Arnold Vulto, Steven Simoens

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published July, 2020

Corporate Taxes,Patent Shifting,and Anti-avoidance Rules: Empirical Evidence

Martina Baumann, Tobias Boehm, Bodo Knoll [...]

Public Finance Review

Restricted accessOtherFirst published March, 2009

Stem Cell Patents—Reexamination/Litigation—The Last 5 Years

Yvonne Shyntum, Edward Kalkreuter

Tissue Engineering Part B: Reviews

Restricted accessResearch articleFirst published April, 2007

Patent Opposition Considerations for the Technology Transfer Professional

Mark B. Wilson, Daniel Alge

Industry and Higher Education

Restricted accessResearch articleFirst published October, 2006

Drugs — Product or Service?

Claus Møldrup, Poul R. Kruse

Journal of Medical Marketing: Device,Diagnostic and Pharmaceutical Marketing

Restricted accessResearch articleFirst published April, 2005

Germany Enacts a Biotechnology Patent Law;AVI BioPharm Receives Stem Cell Antisense Technology Patent and Allowance;Third Amendment to Indian Patent Law Takes Effect;U.S.,Israel in Dispute over Patent Law on Drugs

Biotechnology Law Report

Restricted accessResearch articleFirst published October, 2006

Sanofi,Bristol-Myers Subject of DoJ Investigation;Two Groups Try for Revocation of Human Embryonic Stem Cell Patents;Neuralstem Patent Survives Third Challenge;A Round-Up of New Patents;Protiva Sues Inex

Biotechnology Law Report

Restricted accessNewsFirst published March, 1985

<Blr 349> Text: Speech By Rene G. Tegtmeyer,Assistant Commissioner For Patents,U.S. Patent And Trademark Office,At Third Annual Meeting Of Industrial Biotechnology Association,October 17-18,1984,San Francisco

Biotechnology Law Report

Restricted accessResearch articleFirst published August, 2016

The Medicines Company v. Hospira : When Does Outsourcing Drug Manufacture to a Third-Party Contractor Trigger an On-Sale Bar to Patentability?

Christopher M. Holman

Biotechnology Law Report

Restricted accessResearch articleFirst published April, 2007

MedImmune Case Gets More Complicated: Supreme Court Gives Company Right to Sue,But PTO Revokes Cabilly II for Double Patenting;Israeli Firm Does Not Own Patent on Rheumatoid Arthritis Treatment;Lilly Keeps Its Anti-Schizophrenia Drug Patent;A Win for Abbott;More Trouble for ImClone;Infringement of Ethanol-Manufacture Patent Found to Be Willful;Stratagene,Third Wave Settle PCR Suits;Short Stories

Biotechnology Law Report

Restricted accessResearch articleFirst published March, 2012

Overcoming challenges in market access of generic medicines in the European Union

Pieter Dylst, Arnold Vulto, Steven Simoens

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Restricted accessResearch articleFirst published July, 2020

Corporate Taxes,Patent Shifting,and Anti-avoidance Rules: Empirical Evidence

Martina Baumann, Tobias Boehm, Bodo Knoll [...]

Public Finance Review

Restricted accessOtherFirst published March, 2009

Stem Cell Patents—Reexamination/Litigation—The Last 5 Years

Yvonne Shyntum, Edward Kalkreuter

Tissue Engineering Part B: Reviews

Restricted accessResearch articleFirst published April, 2007

Patent Opposition Considerations for the Technology Transfer Professional

Mark B. Wilson, Daniel Alge

Industry and Higher Education